One signature originally identified in human breast cancer, referred to as Signature 30, was found to be similar to that found following NTHL1 gene deletion, suggestive that “signature 30” may arise from NTHL1 gene mutations. This evidence concerns the gene NTHL1 and breast carcinoma.